**Question:** Carcinoid tumors of lung arises from

A. pulmonary neuroendocrine cells
B. bronchial epithelium
C. alveolar macrophages
D. interstitial lung cells

**Core Concept:**
Carcinoid tumors are a group of neoplasms derived from neuroendocrine cells, which are specialized cells found in the gastrointestinal tract, lungs, and other organs. These tumors are named after the carcinoid syndrome, a group of symptoms caused by the excess release of hormones and amines by these tumors.

In the context of carcinoid tumors in the lung, the correct answer is:

**Correct Answer:** A. pulmonary neuroendocrine cells

Pulmonary neuroendocrine cells, also known as neuroendocrine cells or Type II pneumocytes, are specialized cells found in the lungs. They are part of the respiratory system's defense mechanisms and play a crucial role in the production and secretion of surfactant, a substance that reduces surface tension in the alveoli, allowing the lungs to expand and contract easily during breathing.

**Why the Correct Answer is Right:** Carcinoid tumors of the lung originate from these pulmonary neuroendocrine cells. These cells are responsible for producing and secreting various hormones and amines, which can lead to the carcinoid syndrome when these tumors become active and secrete excess amounts of these substances into the bloodstream.

**Why Each Wrong Option is Incorrect:**

**A. pulmonary neuroendocrine cells:** As explained above, these cells are the correct source of lung carcinoid tumors.

**B. bronchial epithelium:** Bronchial epithelium refers to the cells lining the bronchi, not the cells responsible for carcinoid tumors.

**C. alveolar macrophages:** Alveolar macrophages are immune cells that clean up cellular debris and foreign particles in the alveoli, not the cells responsible for carcinoid tumors.

**D. interstitial lung cells:** Interstitial cells are involved in maintaining lung structure and function, but they are not the origin of lung carcinoid tumors.

**Clinical Pearls:**

Understanding the origin of lung carcinoid tumors is crucial for recognizing these lesions clinically and understanding their potential clinical manifestations due to excess hormone secretion. The carcinoid tumors can produce and release various hormones, such as serotonin, histamine, and kinins, causing symptoms like flushing, diarrhea, bronchoconstriction, and hypotension.

These tumors can also lead to the production of vasoactive amines, such as substance P and serotonin, which contribute to the carcinoid syndrome. Recognizing the correct cell type and understanding the clinical manifestations of excess hormone release can aid in early detection and appropriate management of these tumors.